- Positive Start to Fiscal Year:
- Performance met expectations in Q1.
- Sales and Production:
- Sales lower due to selling built-up inventory in previous quarters.
- Production capacity remained optimal.
- Strong demand for products.
- Capex Updates:
- New R&D facility: Half operational, new molecule development underway.
- More R&D sections to be commissioned in the next few months.
- API block: Plant and lab work ready, equipment qualification ongoing.
- Pilot plant batches to begin in a couple of months.
- Additional fermentation capacity: Civil construction halfway completed.
- Capex execution progressing as planned.
Subscribe To Our Free Newsletter |